(Q38627151)

English

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial

scientific article published on 10 August 2017

In more languages
default for all languages
No label defined

No description defined

Statements

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial (English)
Elizabeth A Ottinger
Nicole Yanjanin Farhat
Elizabeth Berry-Kravis
Ravichandran Rao
Ariane Soldatos
Kimberly A Walters
Bernardus N Machielse
Steven A Silber
Carmen C Brewer
Steven U Walkley
Forbes D Porter

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit